Nam Mekong Group JSC (HNX:VC3)

Market Cap	3.83T
Revenue (ttm)	653.05B
Net Income (ttm)	101.07B
Shares Out	136.41M
EPS (ttm)	703.11
PE Ratio	36.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,055,101
Average Volume	838,066
Open	27,200
Previous Close	27,248
Day's Range	27,200 - 28,100
52-Week Range	23,853 - 28,100
Beta	-0.15
RSI	79.76
Earnings Date	Jul 29, 2025

About Regulus Therapeutics

Nam Mekong Group Joint Stock Company engages in real estate trading, construction, and other activities in Vietnam. It also invests in and develops urban, industrial, and resort real estate properties, as well as invests in renewable energy projects. The company was formerly known as Construction Joint Stock Company No. 3 and changed its name to Nam Mekong Group Joint Stock Company in October 2020. Nam Mekong Group Joint Stock Company was founded in 1992 and is headquartered in Hanoi, Vietnam.

• Industry: Heavy Construction Other Than Building Construction Contractors
• Founded: 1992
• Employees: 76
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: VC3

Financial Performance

In 2024, Nam Mekong Group JSC's revenue was 611.37 billion, a decrease of -24.18% compared to the previous year's 806.32 billion. Earnings were 65.47 billion, a decrease of -53.56%.